Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sam Lovick Consulting is a private Australian economic consulting firm owned by economist Sam Lovick. The business provides advisory, modelling, expert testimony, valuation, and strategic consulting services across multiple sectors including pharmaceuticals, health, energy, utilities, telecommunications, and public policy. In healthcare, the firm appears to focus on health economics, pharmaceutical market analysis, vaccine-market modelling, manufacturing economics, and public-policy support rather than developing therapeutic products. Its publicly described work includes advisory assignments for CSL and Seqirus and economic analyses related to blood products, influenza vaccines, pandemic protection, and manufacturing performance. Overall, it is a specialist consulting business with some life-science sector exposure, not a biotech or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sam Lovick Consulting.